Enveric Biosciences ENVB
NASDAQ ENVB
$1.41 -0.05 (-3.60%)
As of: Oct 23, 2026 · 3:50 PM EDT

Enveric Biosciences (ENVB) Gains from Investment Securities (2015 - 2025)

Updated

Analysis

Enveric Biosciences (ENVB) Gains from Investment Securities (2015 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.26 Bn 1,101.85 Bn 19.71 Bn
2 Johnson & Johnson 635.92 Bn 555.78 Bn 17.30 Bn
3 AbbVie 506.32 Bn 479.44 Bn 12.70 Bn
4 Merck 358.38 Bn 312.76 Bn 12.21 Bn
5 Novartis Ag 293.00 Bn 256.99 Bn 11.24 Bn
6 Astrazeneca 265.76 Bn 239.44 Bn 12.86 Bn
7 Amgen 237.88 Bn 193.27 Bn 7.24 Bn
8 Gilead Sciences 195.26 Bn 169.45 Bn 6.22 Bn
9 Pfizer 171.34 Bn 117.99 Bn 10.94 Bn
10 Enveric Biosciences 5.66 Mn -15.98 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 1,707.00
Dec 31, 2024 2,956.00
Sep 30, 2024 -501.00
Jun 30, 2024 7,767.00
Mar 31, 2024 11,398.00
Sep 30, 2023 562,715.00
Jun 30, 2023 -1.08 Mn
Mar 31, 2023 119,505.00
Dec 31, 2022 1.66 Mn
Sep 30, 2022 1.81 Mn
Jun 30, 2022 -53,000.00
Jun 30, 2015 340,000.00
API Access

Enveric Biosciences Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=ENVB&period=max&api_key=YOUR_API_KEY